Literature DB >> 33124076

ECMO therapy in COVID-19: An experience from Zurich.

Juri Sromicki1, Martin Schmiady1, Francesco Maisano1, Carlos A Mestres1,2.   

Abstract

BACKGROUND: The current coronavirus disease 2019 (COVID-19) pandemic has a huge impact on society and the economy and represents one of the biggest challenges for healthcare systems all over the world. Reports from healthcare institutions in different countries show a variety of crisis exit strategies.
METHODS: The following is a review and update of the situation and crisis management in Zürich and Switzerland with a special focus on the impact on the cardiac surgery program and extracorporeal membrane oxygenation (ECMO)-therapy in COVID-19.
RESULTS: Regional and national measures had avoided the collapse of the health system in Switzerland. There was a reduction of over 50% of the surgical and transcatheter caseload during the first wave of the pandemic. Twenty-three ECMO devices, 150 oxygenators, and more than 300 different cannulas were at our disposal. Between March and May 2020, nine COVID-19 patients were treated by us with ECMO-therapy. Three patients were transported by us from distant institutions. Median age at ECMO implantation was 59 years. Two patients died on support.
CONCLUSIONS: Measures to prevent a collapse of the healthcare system were effective. Our local ECMO-Program on the ongoing COVID-19 pandemic has proven to be a useful tool to control mortality and organ failure in critically ill patients.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; ECMO; Switzerland; cardiac surgery

Year:  2020        PMID: 33124076     DOI: 10.1111/jocs.15147

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  6 in total

Review 1.  Mechanical Circulatory Support in COVID-19.

Authors:  Kari Gorder; Wesley Young; Navin K Kapur; Timothy D Henry; Santiago Garcia; Raviteja R Guddeti; Timothy D Smith
Journal:  Cardiol Clin       Date:  2022-03-25       Impact factor: 2.410

2.  Treatment of acute respiratory distress syndrome from COVID-19 with extracorporeal membrane oxygenation in obstetrical patients.

Authors:  Emily Shih; J Michael DiMaio; John J Squiers; Anita R Krueger; Gary S Schwartz; James Herd; April T Bleich
Journal:  Am J Obstet Gynecol MFM       Date:  2021-11-20

Review 3.  Temporary mechanical circulatory support for COVID-19 patients: A systematic review of literature.

Authors:  Silvia Mariani; Maria Elena De Piero; Justine M Ravaux; Alexander Saelmans; Michal J Kawczynski; Bas C T van Bussel; Michele Di Mauro; Anne Willers; Justyna Swol; Mariusz Kowalewski; Tong Li; Thijs S R Delnoij; Iwan C C van der Horst; Jos Maessen; Roberto Lorusso
Journal:  Artif Organs       Date:  2022-05-01       Impact factor: 2.663

4.  Extracorporeal membrane oxygenation for respiratory failure in phases of COVID-19 variants.

Authors:  Emily Shih; J Michael DiMaio; John J Squiers; Arundhati Rao; Gelareh Rahimighazikalayeh; Talia C Meidan; Kara A Monday; Britton Blough; Dan Meyer; Gary S Schwartz; Timothy J George
Journal:  J Card Surg       Date:  2022-04-30       Impact factor: 1.778

5.  Hyperglycemia and Hypoglycemia Are Associated with In-Hospital Mortality among Patients with Coronavirus Disease 2019 Supported with Extracorporeal Membrane Oxygenation.

Authors:  Kuk Hui Son; Woong-Han Kim; Jae Gun Kwak; Chang-Hyu Choi; Seok In Lee; Ui Won Ko; Hyoung Soo Kim; Haeyoung Lee; Euy Suk Chung; Jae-Bum Kim; Woo Sung Jang; Jae Seung Jung; Jieon Kim; Young Kyung Yoon; Seunghwan Song; Minji Sung; Myung Hun Jang; Young Sam Kim; In-Seok Jeong; Do Wan Kim; Tae Yun Kim; Soon Jin Kim; Su Wan Kim; Joonhwa Hong; Hyungmi An
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

6.  Bloodstream and respiratory coinfections in patients with COVID-19 on ECMO.

Authors:  Emily Shih; J Michael DiMaio; John J Squiers; Jasjit K Banwait; Howard M Kussman; David P Meyers; Talia G Meidan; Jenelle Sheasby; Timothy J George
Journal:  J Card Surg       Date:  2022-09-08       Impact factor: 1.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.